New indaniloxi dihidrobenzofuranil acetic acids

摘要

The Invention relates to compounds of the General formula I, where the Group G1 AR (HET) is defined according to claim 1, which bind to the receptor GPR40 and modulate its activity.Such compounds are suitable for the treatment and Prevention of diseases which can be influenced by this receptor, such as Metabolic Diseases, including Type 2 diabetes.Preferred compounds are: acid (S) - 6 - [(R) - 5 - fluoro - 2 - 4 - pirid iloxi - indan - 1 - iloxi] - 2,3 dihydro - benzofuran - 3 - {il} - acetic acid (S) - 6 - [(R) - 4 - (4 - cyano - phenoxy) - 5 - fluoro - indan] - 1 - iloxi 2,3 dihydro - methane - il - 3} - acetic acid, among others